The mental health workforce needs pharmacists
Am J Health-Syst Pharm. 2023;80:xxx-xxx December
Dopheide JA, Onyema I, Casey T, Goodwin H, Moore T, Payne G.
2023
This commentary discusses how pharmacists can participate in improving mental health care globally by developing skills in mental health and substance use disorder care.
Read More
Positioning Psychiatric Pharmacists to Improve Mental Health Care
The mental health clinician, 12 (2): 77–85.
Dopheide JA, Werremeyer A, Haight RJ, Gutierrez CA, Williams AM.
2023
Authors present the evolution of psychiatric pharmacy and describe practice roles for psychiatric pharmacists.
Read More
Best practices for documentation of psychotropic drug-drug interactions in an adult psychiatric clinic.
Ment Health Clin [Internet]. 2023;13(1):11-7.
Collins K, Dopheide JA, Wang M, Keshishian T.
2023
Authors collect data on psychotropic drug interactions in an adult psychiatric clinic over a one-year period and make recommendations for improving documentation, monitoring and patient education on drug interactions.
Read More
Do pharmacist employers prefer or require board certification?
Journal of the American Pharmacists Association
Fay Goldenshteyn, Julie Ann Dopheide, Mimi Lou
2019
The pharmacy profession has promoted the value of board certification, yet the impact of board certification on employment opportunities for pharmacists is largely unknown. This study aims to report employer preferences for board certification as indicated on job listings.
Read More
Pharmacy resident teaching in psychiatry and neurology for pharmacy programs in the United States
The Mental Health Clinician
Julie Ann Dopheide
2018
The American Society of Health-System Pharmacists' Postgraduate Year 1 and Year 2 Residency Accreditation Standards require that residents demonstrate effective teaching skills. The College of Psychiatric and Neurologic Pharmacists' survey of pharmacy program curricula assessed resident teaching in psychiatry and neurology, however, results were not published. The objective of this article is to describe resident teaching in psychiatry and neurology curricula as reported by responses to the college's survey.
Read More
Curriculum in Psychiatry and Neurology for Pharmacy Programs
American Journal of Pharmaceutical Education
Julie Ann Dopheide; Lisa W Goldstone
2017
To describe pharmacy curricula in psychiatry and neurology and to report on neuropsychiatric pharmacy specialists' views on optimal curriculum. Design and administer one electronic survey to accredited pharmacy programs asking them to report information on curricula in psychiatry and neurology for the 2014-2015 academic year. Design and administer a separate electronic survey to board certified pharmacists with an academic affiliation who are members of the College of Psychiatric and Neurologic Pharmacists (CPNP) asking about their teaching activities and their opinion on optimal curricula. Fifty-six percent of pharmacy programs and 65% of CPNP members responded to the surveys. The program survey revealed greater than 80% of topics were taught by full-time faculty. Didactic lecturing, team-based learning, and case studies were the most common teaching methods. Programs dedicated the most didactics (3 to 5+ hours) to epilepsy, depression, schizophrenia, substance use disorders, and pain. Autism, traumatic brain injury, personality, and eating disorders were either not taught or given ≤ 1 hour of didactics in most programs. Inpatient psychiatry had the most APPE placements with a mean of 19.6, range 0-83. APPE electives in psychiatry outnumbered those in neurology 5 to 1. CPNP member survey results showed 2 out of 3 members agreed that curriculum could be improved with additional APPEs in psychiatry and neurology. Didactic hour distribution in psychiatry and neurology could be improved to better align with board certification in psychiatric pharmacy (BCPP) recommendations and disorder prevalence and complexity. Specialists recommend an experiential component in neurology and psychiatry to combat stigma and improve pharmacist knowledge and skills.
Read More
Antipsychotic Selection for Acute Agitation and Time to Repeat Use in a Psychiatric Emergency Department
Journal of Psychiatric Practice
Julie Ann Dopheide
2016
Early recognition and treatment of agitated patients is essential to avoid violence in the psychiatric emergency department (ED). Antipsychotics have established efficacy in managing agitation, yet little is known about how the choice of initial antipsychotic impacts time to repeat use and length of stay (LOS) in the psychiatric ED.
Read More
Acetylcysteine for treatment of autism spectrum disorder symptoms
Am J Health Syst Pharm
2015
A 17-year-old Hispanic male with ASD and intellectual disability was hospitalized for inpatient psychiatric treatment due to impulsive and violent behavior. Despite receiving various medications in the initial weeks of hospitalization, including intramuscular lorazepam and diphenhydramine injections (four days a week on average), the patient continued to exhibit aggressive and unpredictable behaviors.
Read More
Nonpsychiatric medication interventions initiated by a postgraduate year 2 psychiatric pharmacy resident in a patient-centered medical home.
The Primary Care Companion for CNS Disorders
Williams AM, Dopheide JA
2014
Studies have demonstrated the benefits of incorporating comprehensive medication management into primary care, but no study describes the types of nonpsychiatric medication-related interventions provided by a psychiatric pharmacist while providing comprehensive medication management.
Read More
Psychiatric pharmacist management of depression in patients with diabetes.
The Primary Care Companion for CNS Disorders
Nazarian PK, Dopheide JA
2013
Read More
Depression Screening in a University Campus Pharmacy: A Pilot Project
Journal of the American Pharmacists Association
Dopheide JA, Werremeyer A, Haight RJ, Gutierrez CA, Williams AM.
2006
To evaluate the usefulness of a depression screening tool in a university campus pharmacy.
Read More
Factors influencing performance on the Board Certified Psychiatric Pharmacist Examination: Passing rates and domain-level scores.
Ment Health Clin [Internet]. 2021;11(6):358-64. DOI: 10.9740/mhc.2021.11.358
Muckle TJ, Dopheide JA, Gable K, Meng Y, Johnson SG, Ellis W.
2021
Pharmacists with residency training in psychiatric pharmacy are significantly more likely to pass the board certification exam and become board certified psychiatric pharmacists.
Read More
“Changing Manufacturer to Address Nonclozapine Antipsychotic Neutropenia: case reports”.
Journal of the American Pharmacists Association 2022. https://doi.org/10.1016/j.japh.2022.04.010
Antipsychotics manufactured by different companies include different fillers and excipients. Two cases are presented where neutropenia improves when the patient transitions from one manufacturer of the antipsychotic to a different manufacturer. The authors propose, these different ingredients may contribute to the development of neutropenia from antipsychotics.
Read More
